Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Pouchitis
NCT02428361Phase 1Completed
- Start
- May 2015
- Primary completion
- Apr 2018
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of biologically active human fecal material in pouchitis. Primary endpoint: Clinical improvement of pouchitis at 4 weeks. Started May 2015; status: completed.
02
Drugs
biologically active human fecal material
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT02428361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428361.